AAV-mediated gene transfer of a checkpoint inhibitor in combination with HER2-targeted CAR-NK cells as experimental therapy for glioblastoma.

Saved in:
Bibliographic Details
Title: AAV-mediated gene transfer of a checkpoint inhibitor in combination with HER2-targeted CAR-NK cells as experimental therapy for glioblastoma.
Authors: Strecker MI; Senckenberg Institute of Neurooncology, Goethe University, Frankfurt, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt, Germany.; Frankfurt Cancer Institute, Goethe University, Frankfurt, Germany., Wlotzka K; Senckenberg Institute of Neurooncology, Goethe University, Frankfurt, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt, Germany.; Frankfurt Cancer Institute, Goethe University, Frankfurt, Germany., Strassheimer F; Senckenberg Institute of Neurooncology, Goethe University, Frankfurt, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt, Germany.; Frankfurt Cancer Institute, Goethe University, Frankfurt, Germany., Roller B; Senckenberg Institute of Neurooncology, Goethe University, Frankfurt, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt, Germany.; Frankfurt Cancer Institute, Goethe University, Frankfurt, Germany., Ludmirski G; Senckenberg Institute of Neurooncology, Goethe University, Frankfurt, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt, Germany.; Frankfurt Cancer Institute, Goethe University, Frankfurt, Germany., König S; Senckenberg Institute of Neurooncology, Goethe University, Frankfurt, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt, Germany.; Frankfurt Cancer Institute, Goethe University, Frankfurt, Germany., Röder J; Frankfurt Cancer Institute, Goethe University, Frankfurt, Germany.; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt, Germany., Opitz C; Institute for Transfusion Medicine, German Red Cross Blood Donation Service North-East and Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany., Alekseeva T; Frankfurt Cancer Institute, Goethe University, Frankfurt, Germany.; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt, Germany., Reul J; Paul-Ehrlich-Institut, Molecular Biotechnology and Gene Therapy, Langen, Germany., Sevenich L; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt, Germany.; Frankfurt Cancer Institute, Goethe University, Frankfurt, Germany.; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt, Germany., Tonn T; Institute for Transfusion Medicine, German Red Cross Blood Donation Service North-East and Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany.; German Cancer Consortium (DKTK), partner site Dresden, Dresden, Germany., Wels WS; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt, Germany.; Frankfurt Cancer Institute, Goethe University, Frankfurt, Germany.; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt, Germany., Steinbach JP; Senckenberg Institute of Neurooncology, Goethe University, Frankfurt, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt, Germany.; Frankfurt Cancer Institute, Goethe University, Frankfurt, Germany., Buchholz CJ; Frankfurt Cancer Institute, Goethe University, Frankfurt, Germany.; Paul-Ehrlich-Institut, Molecular Biotechnology and Gene Therapy, Langen, Germany.; German Cancer Consortium (DKTK), partner site Heidelberg, Heidelberg, Germany., Burger MC; Senckenberg Institute of Neurooncology, Goethe University, Frankfurt, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt, Germany.; Frankfurt Cancer Institute, Goethe University, Frankfurt, Germany.
Source: Oncoimmunology [Oncoimmunology] 2022 Oct 11; Vol. 11 (1), pp. 2127508. Date of Electronic Publication: 2022 Oct 11 (Print Publication: 2022).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2162-402X
DOI:10.1080/2162402X.2022.2127508